Funding for this research was provided by:
Eli Lilly and Company
Text and Data Mining valid from 2018-05-08
Received: 27 October 2017
Accepted: 4 April 2018
First Online: 8 May 2018
Ethics approval and consent to participate
: Not applicable.
: MHC has participated in Abasaglar speaker events for which he received honorarium from Eli Lilly and Company and Boehringer-Ingelheim. LLI, DC, and IH are employees of and hold stock in Eli Lilly and Company. MHT is a retiree of Eli Lilly and Company. This study was previously published in part as two abstracts, the first at the American Diabetes Association’s 76th Annual Scientific Sessions in New Orleans, LA, USA in June 2016 and the second at Diabetes UK Professional Conference, Manchester, UK in March 2017.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.